Michael M. Lederman

34.4k citations
432 papers · 28.7k · 7 hit papers · h-index 85

Impact in

Papers in

    • HIV Research and Treatment 220
    • HIV/AIDS drug development and treatment 67
    • HIV/AIDS Research and Interventions 61

Michael M. Lederman

419 papers receiving 27.8k citations

Michael M. Lederman's Hit Papers

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality 2014 · 500 citations
5000+10+20Years since publication50010001.5k2.0k2.5k

Peers

Michael M. Lederman
Comparison fields: 5 of 175
  • Virology 12.2k
  • Emergency Medicine 4.3k
  • Infectious Diseases 8.3k
  • Immunology 8.0k
  • Microbiology 1.2k
Replace ALAN L. LANDAY with:
ALAN L. LANDAY United States
Jason M. Brenchley United States
Jeffrey N. Martin United States
John Phair United States
Joseph M. McCune United States
Adriano Lazzarin Italy
Bonaventura Clotet Spain
Giuseppe Pantaleo Switzerland
Benigno A. Rodriguez United States
Sharon Ruth Lewin Australia
Michael M. Lederman relative to ALAN L. LANDAY United States ALAN L. LANDAY's profile →
Citations per field
00.5×1.5×
ALAN L. LANDAY · 1×
Citations per year

Countries citing papers authored by Michael M. Lederman

Since Specialization
Citations

This map shows the geographic impact of Michael M. Lederman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Lederman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Lederman more than expected).

Fields of papers citing papers by Michael M. Lederman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Lederman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Lederman. The network helps show where Michael M. Lederman may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael M. Lederman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael M. Lederman Line = papers co-authored together Michael M. Lederman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 432 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Hit paper breakdown →
20062944
2
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
Hit paper breakdown →
1996836
3
Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
Hit paper breakdown →
2013599
4
Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
Hit paper breakdown →
2009504
5
HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
Hit paper breakdown →
2014500
6
Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment
Hit paper breakdown →
2014459
7 1989456
8
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Hit paper breakdown →
2014421
9 2003375
10 1998366
11 2007323
12 2013313
13 2004310
14 2004303
15 2018300
16 2014294
17 2010288
18 1983285
19 2009282
20 2011276

About Michael M. Lederman

Michael M. Lederman is a scholar working on Virology, Infectious Diseases, Immunology, Emergency Medicine and Epidemiology, having authored 432 papers that have together received 28.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (220 papers), Immune Cell Function and Interaction (94 papers), HIV/AIDS drug development and treatment (67 papers), HIV-related health complications and treatments (67 papers), HIV/AIDS Research and Interventions (61 papers), T-cell and B-cell Immunology (40 papers), Pneumocystis jirovecii pneumonia detection and treatment (29 papers) and Cytomegalovirus and herpesvirus research (28 papers). The work is most often cited by research in Virology (12.2k citations), Emergency Medicine (4.3k citations), Infectious Diseases (8.3k citations), Immunology (8.0k citations) and Microbiology (1.2k citations). Michael M. Lederman has collaborated with scholars based in United States, South Africa and Canada. Frequent co-authors include Benigno A. Rodriguez, Scott F. Sieg, ALAN L. LANDAY, Nicholas Funderburg, Steven Grant Deeks, Hernán Valdez, Jeffrey N. Martin, Peter W. Hunt, Daniel C. Douek and Robert J. Asaad. Their work appears in journals such as The Journal of Infectious Diseases, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact